Protective effect of the nuclear factor kappa B inhibitor pyrrolidine dithiocarbamate in lung injury in rats with streptozotocin-induced diabetes

Respiration

Volumn 79, Issue 5, 2010, Pages 402-410

  Eren, Gulay ^a   Cukurova, Zafer ^a   Hergunsel, Oya ^a   Demir, Guray ^a   Kucur, Mine ^c   Uslu, Ezel ^c   Dalo, Enis ^c   Uhri, Mehmet ^a   Tugcu, Volkan ^b  

^a Bakirkoy Dr Sadi Konuk Training and Research Hospital   (United States)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Diabetic complications; Eendothelial; Lung injury; Nitric oxide synthase; Nuclear factor kappa B; Oxidative stress

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LUNG INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; LUNG; LUNG INJURY; MEMBRANES; MICROSCOPY; NF-KAPPA B; NITRIC OXIDE; PROTEIN CARBONYLATION; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIOCARBAMATES; TRANSCRIPTION FACTOR RELA;

EID: 77951295862     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264920     Document Type: Article

References (36)

1. Keays R: Diabetes. Curr Anaesth Crit Care 2007; 18: 69-75. (Pubitemid 47335574)
2. Sandler M: Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med 1990; 150: 1385-1388. (Pubitemid 20215675)
3. Oztay F, Kandil A, Gurel E, Ustunova S, Kapucu A, et al: The relationship between nitric oxide and leptin in the lung of rat with streptozotocin- induced diabetes. Cell Biochem Funct 2008; 26: 162-171. (Pubitemid 351373962)
4. Błaszczak R, Kȩdziora J, Ertel D, Rutkowski M, et al: Selected antioxidative enzyme activities in patients with diabetes mellitus type 2. Arch Med Sci 2005; 1: 144-147.
5. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E: Nuclear factor-kappa B is activated in alveolar macrophages from patients with the acute respiratory distress syndrome. Crit Care Med 1996; 24: 1285-1292. (Pubitemid 26262400)
6. He Z, Li B, Yu L, Liu Q, Zhong N, Ran P: Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells. Respiration 2008; 75: 202-209. (Pubitemid 351363876)
7. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, et al: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharma 2002; 135: 496-510. (Pubitemid 34151183)
8. Yagi O, Aoshiba K, Nagai A: Activation of nuclear factor-kappaB in airway epithelial cells in patients with chronic obstructive pulmonary disease. Respiration 2006; 73: 610-616. (Pubitemid 44481477)
9. Telci A, Cakatay U, Kayali R, Erdogan C, Orhan Y, Sivas A, Akcay T: Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 2000; 32: 40-43. (Pubitemid 30126721)
10. Carrard G, Bulteau AL, Petropoulos I, Friguet B: Impairment of proteasome structure and function in aging. Int J Biochem Cell Bio 2002; 34: 1461-1474. (Pubitemid 35245402)
11. Stadtman ER, Levine RL: Protein oxidation, Ann NY Acad Sci 2000; 899: 191-208.
12. Cakatay U, Telci A, Kayali R, Tekeli F, Akcay T, Sivas A: Relation of aging with oxidative protein damage parameters in the rat skeletal muscle. Clin Biochem 2003; 36: 51-55. (Pubitemid 36126390)
13. Evans P, Lyras L, Halliwell B: Measurement of protein carbonyls in human brain tissue. Method Enzymol 1999; 300: 145-156.
14. Reznik AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Method Enzymol 1994; 233: 357-363. (Pubitemid 24177561)
15. Tugcu V, Ozbek E, Tasci AI, Kemahli E, Somay A, Bas M, et al: Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin. BJU Int 2006; 98: 680-686. (Pubitemid 44201902)
16. Tugcu V, Ozbek E, Kemahli E, Cekmen MB, et al: Rapid communication: protective effect of a nuclear factor kappaB inhibitor, pyrrolidium dithiocarbamate, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 2007; 21: 1097-1106. (Pubitemid 47608916)
17. Hurdag C, Uyanerb I, Gurelb E, Utkusavas A, Atukerend P, Demirci C: The effect of α- lipoic acid on NOS dispersion in the lung of streptozotocin-induced diabetic rats. J Diabetes Complicat 2008: 22: 56-61.
18. McNaughton L, Puttagunta L, Martinez- Cuesta MA, Kneteman N, Mayers I, Moqbel R, et al: Distribution of nitric oxide synthase in normal and cirrhotic human liver. P Natl Acad Sci USA 2002; 2499: 17161-17166. (Pubitemid 36034115)
19. Elman GL: Tissue sulfhydryl groups. Arch Biochem Biophys1959; 82: 70-77.
20. Sun Y, Oberley LW, Li YA: Simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
21. Lowry OH, Rosebrough NJ, Farr AC, Randall RJ: Protein measurement with the folinphenol reagent. J Biol Chem 1951; 193: 265.
22. Weynand B, Jonckheere A, Frans A, Rahier J: Diabetes mellitus induces a thickening of the pulmonary basal laminae. Respiration 1999; 66: 14-19. (Pubitemid 29089987)
23. Popov D, Simionescu M: Alterations of lung structure in experimental diabetes and diabetes associated with hyperlipidemia in hamsters. Eur Respir J 1997; 10: 1850-1858. (Pubitemid 27368381)
24. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch J: Diabetes and advanced glycoxidation end products. Diabetes Care 2006; 29: 1420-1432. (Pubitemid 44125953)
25. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T, et al: Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha- lipoic acid in cultured endothelial cells. Diabetes 1997; 46: 1481-1490. (Pubitemid 27369087)
26. Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ: Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 2008; 21: 28-34.
27. Turko IV, Marcondes S, Murad F: Diabetesassociated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 2001; 281: 2289-2294. (Pubitemid 33776599)
28. Vega-Lopez S, Devaraj S, Jialal I: Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J Investig Med 2004; 52: 24-32. (Pubitemid 38248892)
29. Johansen JS, Harris AK, Rychly DJ, Ergul A: Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol 2005; 4: 5. DOI: 10.1186/1475-2840-4-5. (Pubitemid 41460764)
30. Sridulyakul P, Chakraphan D, Bhattarakosol P, Patumraj S: Endothelial nitric oxide synthase expression in systemic and pulmonary circulation of streptozotocin induced diabetic rats: comparison using image analysis. Clin Hemorheol Micro 2003; 29: 423-428. (Pubitemid 38130416)
31. Aytacoglu BN, Calikoglu M, Tamer L, Coşkun B, Sucu N, Köse N, Aktas S, Dikmengil M: Alcohol-induced lung damage and increased oxidative stress. Respiration 2006; 73: 100-104. (Pubitemid 43296246)
32. Yao J, Liu Y, Wang X, Shen Y, Yuan S, Wan Y, Jiang Q: UVB radiation induces human lens epithelial cell migration via NADPH oxidase- mediated generation of reactive oxygen species and up-regulation of matrix metalloproteinases. Int J Mol Med 2009; 24: 153-159.
33. Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxic 2003; 17: 24-38.
34. Berlett BS, Stadtman ER: Protein oxidation in aging, disease, and oxidative stress. Am Soc Biochem Mol Biol 1997; 272: 20313-20316. (Pubitemid 27355575)
35. Dursun E, Timur M, Dursun B, Süleymanlar G, Ozben T: Protein oxidation in type 2 diabetic patients on hemodialysis. J Diabetes Complicat 2005; 19: 142-146. (Pubitemid 40615545)
36. Aso Y, Inukai T, Tayama K, Takemura Y: Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol 2000; 37: 87-92. (Pubitemid 32009315)